A biopharmaceutical company is suing the Drug Enforcement Administration (DEA) over what it called unjustified delays to its application to
The Drug Enforcement Agency’s (DEA) Administrator, Anne Milgram, has come under fire from GOP congressmen over the apparent divergence of
Reports from last week suggesting that the US Drug Enforcement Administration (DEA) would support recommendations for cannabis rescheduling were not
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
